Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV. (Q51942900)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 April 2006

Language	Label	Description	Also known as
English	Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV.	scientific article published on 27 April 2006

Statements

scholarly article

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV. (English)

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

cerebrospinal fluid

0 references

author name string

Richard J Noel

1

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

Ziomara Marrero-Otero

2

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

Rakesh Kumar

3

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

Gladys S Chompre-González

4

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

Ashish S Verma

5

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

Anil Kumar

6

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

language of work or name

0 references

publication date

27 April 2006

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

349

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

2

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

440-452

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Increased replication of simian immunodeficiency virus in CEM x174 cells by morphine sulfate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Opioids and the progression of simian AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Structure of simian immunodeficiency virus regulatory genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Early viral brain invasion in iatrogenic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Tat protein from human immunodeficiency virus forms a metal-linked dimer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Development and characterization of positively selected brain-adapted SIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Human immunodeficiency virus-associated meningitis. Clinical course and correlations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

HIV-1 protein Tat reduces the glutamate-induced intracellular Ca2+ increase in cultured cortical astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Morphine Enhances HIV Infection of Neonatal Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Influence of CD4+ T cell counts on viral evolution in HIV-infected individuals undergoing suppressive HAART

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Mutation pattern of human immunodeficiency virus gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

The AIDS dementia complex: II. Neuropathology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

The AIDS dementia complex: I. Clinical features

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-kappaB activation and oxidative stress in microglial cultures by independent mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

HIV-1 tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Detecting hypermutations in viral sequences with an emphasis on G --> A hypermutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Acute ataxia coincident with seroconversion for anti-HIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Pathogenic and nef-interrupted simian-human immunodeficiency viruses traffic to the macaque CNS and cause astrocytosis early after inoculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Morphine-induced transactivation of HIV-1 LTR in human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

μ-opioid modulation of HIV-1 coreceptor expressionand HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Evolution of SIV envelope in morphine-dependent rhesus macaques with rapid disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

G-->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Morphine and Endomorphins Differentially Regulate μ-Opioid Receptor mRNA in SHSY-5Y Human Neuroblastoma Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Cocaine opens the blood-brain barrier to HIV-1 invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

Reappearance of founder virus sequence in human immunodeficiency virus type 1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular basis for interactions of HIV and drugs of abuse.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

based on heuristic

inferred from DOI database lookup

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2006.03.032

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16643974

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51942900&oldid=1382285335"